Home
/
Treatment
/
Glasdegib

Glasdegib

	Glasdegib
Trade Name
Orphan Indication	Acute myeloid leukemia
USA Market Approval	USA
USA Designation Date	2017-06-28 00:00:00
Sponsor	Pfizer, Inc.;445 Eastern Point Road;Groton, Connecticut, 06340

Related Access Program

Children’s Hospital Los Angeles – Acute myeloid leukemia Jazz Pharmaceuticals – Secondary AML Celator Pharmaceuticals – Secondary AML University of California, San Francisco – Acute myeloid leukemia Emory University – Acute myeloid leukemia